DOCSLIB.ORG

Programma Najaarsvergadering 7 En 8 Oktober 2010

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Programma Najaarsvergadering 7 En 8 Oktober 2010 Programma najaarsvergadering 7 en 8 oktober 2010 NEDERLANDSE VERENIGING VOOR GASTROENTEROLOGIE Sectie Gastrointestinale Endoscopie Netherlands Society for Parenteral and Enteral Nutrition Sectie Neurogastroenterologie en Motiliteit Sectie Experimentele Gastroenterologie Sectie Kinder-MDL Sectie Endoscopie Verpleegkundigen en Assistenten Vereniging Maag Darm Lever Verpleegkundigen NEDERLANDSE VERENIGING VOOR HEPATOLOGIE NEDERLANDSE VERENIGING VOOR GASTROINTESTINALE CHIRURGIE NEDERLANDSE VERENIGING VAN MAAG-DARM-LEVERARTSEN Locatie: NH KONINGSHOF VELDHOVEN INHOUDSOPGAVE pag Voorwoord 4 Belangrijke mededeling aan alle deelnemers aan de najaarsvergadering 5 Programma cursorisch onderwijs in mdl-ziekten 6 oktober 2010 6 Schematisch overzicht donderdag 7 oktober 2010 8 Schematisch overzicht vrijdag 8 oktober 2010 9 PROGRAMMA DONDERDAG 7 OKTOBER (aanvang 10.00 uur) IBD Symposium: “Optimale inzet van medicatie bij IBD” 10 Vrije voordrachten Nederlandse Vereniging voor Hepatologie 10 Vrije voordrachten Nederlandse Vereniging voor Gastrointestinale Chirurgie 13 Vrije voordrachten Nederlandse Vereniging voor Gastroenterologie 15 Symposium Sectie Neurogastroenterologie: “De dysmotore slokdarm” 15 Vrije voordrachten Nederlandse Vereniging voor Gastroenterologie 16 Tytgat Lecture 17 President Select sessie (plenair) 17 Uitreiking Janssen-Cilag Gastrointestinale Research-prijs 2010 18 Vrije voordrachten Nederlandse Vereniging voor Hepatologie 18 Symposium NVH: "Portale hypertensie en Leverfalen" 18 Vrije voordrachten Nederlandse Vereniging voor Hepatologie 20 Workshop Landelijke Colonstent database 22 Vrije voordrachten Nederlandse Vereniging voor Gastrointestinale Chirurgie 23 Mini-symposium NVGIC: “Diagnostiek en behandeling van cysteuze pancreaslaesies in de praktijk” 23 Vrije voordrachten Nederlandse Vereniging voor Gastrointestinale Chirurgie 25 Programma Hepatitis Verpleegkundigen 26 Tijdstippen diverse ledenvergaderingen donderdag Nederlandse Vereniging voor Gastroenterologie 7 oktober, 11.30 uur – Brabantzaal NVMDL i.o. 7 oktober, 12.00 uur – Zaal 81 / 82 Nederlandse Vereniging voor Hepatologie 7 oktober, 15.30 uur – Baroniezaal 2 INHOUDSOPGAVE pag PROGRAMMA VRIJDAG 8 OKTOBER (aanvang 08.30 uur) Vrije voordrachten Sectie Gastrointestinale Endoscopie 28 Jubileumsymposium 30 jaar SGE: ‘Choices in Endoscopy’ 29 Vrije voordrachten Nederlandse Vereniging voor Gastroenterologie - Baroniezaal 30 Vrije voordrachten Nederlandse Vereniging voor Gastroenterologie – Parkzaal 34 Vrije voordrachten NVGE / NESPEN 37 Symposium ’25 jaar Stichting Opsporing Erfelijke Tumoren’ 38 Mini-symposium ‘Richtlijn acute bloedingen uit de tractus digestivus’ 40 Programma Verpleegkundigen & Verzorgenden MDL Nederland (SEVA / VMDLV) 41 Abstracts najaarscongres 42-133 Plattegrond expositie en overzicht aanwezige bedrijven 134-135 Aanmeldingsformulieren lidmaatschappen 137-139 Tijdstippen diverse ledenvergaderingen vrijdag: Sectie Endoscopie Verpleegkundigen en Assistenten 8 oktober, 11.45 uur - Diezezaal Nederlandse Vereniging van Maag-Darm-Leverartsen 8 oktober, 12.00 uur - Genderzaal Aandachtspunt voor de sprekers: u dient zich strikt te houden aan de beschikbare spreektijd! U vindt dit aangegeven bij de betreffende sessie. In zaal 25 kunt u uw PowerPoint presentatie inleveren tot uiterlijk 30 minuten voor uw voordracht. 3 VOORWOORD Hierbij treft u het programma aan van de najaarsvergadering die gehouden wordt op 7 en 8 oktober a.s. in Congrescentrum NH Koningshof te Veldhoven. Ook dit keer worden deze dagen vooraf gegaan door het cursorisch onderwijs in maag- darm-leverziekten, waarvan u het programma aantreft op bladzijde 6-7. Het programma zal donderdag 8 oktober om 10.00 uur van start gaan met het eerste symposium van de nieuw opgerichte IBD-werkgroep, getiteld: ‘Optimale inzet van medi- catie bij IBD’. Parallel aan dit symposium kunnen in respectievelijk de Baroniezaal en het Auditorium de presentaties van de Nederlandse Vereniging voor Hepatologie en Nederlandse Vereniging voor Gastro Enterologie worden gevolgd. Na de lunch in de expositiehal, vindt in de middag onder andere een symposium over de dysmotore slokdarm plaats, een symposium van de NVH over leverfalen en hypertensie en een workshop Landelijke Colonstent database. Aan het einde van de middag zal in de Brabantzaal de ‘Tytgat Lecture’ worden gegeven, ditmaal door prof. dr. E. Van Cutsem uit Leuven met een voordracht getiteld: ‘Op weg naar een meer gepersonaliseerde therapie voor colorectale kanker’. Om 17.00 volgt de President Select en om 18.00 uur aansluitend de uitreiking van de Janssen Cilag Gastrointestinale Research Award 2010. De eerste prijswinnaar zal na de uitreiking een erevoordracht houden. Met deze lezing wordt het programma van de donderdag afgesloten. In de avond is er geen programma ingepland. Het diner vindt plaats in de Genderzaal, daarna, vanaf omstreeks 22.30 uur, is er muziek in de Baroniezaal en de gebruikelijke congresborrel in de Limburgfoyer. Op vrijdagochtend starten de abstractpresentaties in verschillende zalen alweer om 08.30 uur. In de Brabantzaal wordt het 30-jarig bestaan van de Sectie Gastrointestinale Endo- scopie gevierd met een groot symposium getiteld ‘Choices in Endoscopy’. In de middag vindt er eveneens een jubileumsymposium plaats in de Brabantzaal in verband met het 25-jarig bestaan van de Stichting Opsporing Erfelijke Tumoren. Parallel daaraan in de Baroniezaal de richtlijnbijeenkomst Bloedingen. In de Diezezaal tenslotte, worden door Verpleegkundigen & Verzorgenden MDL (SEVA / VMDLV) een eigen programma met lezingen verzorgd. Graag tot ziens in Veldhoven! Dr. R.J.F. Felt-Bersma, secretaris Nederlandse Vereniging voor Gastroenterologie Let op: indien u gebruik maakt van overnachting in Koningshof dan dient u op de dag van vertrek de kamer vóór 10.00 uur te verlaten en de keycard in te leveren bij de receptie. Na dit tijdstip zullen er door Koningshof extra kosten in rekening worden gebracht. Uw bagage kunt u desgewenst in een locker deponeren. Deze vindt u nabij de hoofdingang. 4 Belangrijke mededeling over de aanwezigheid van farmaceutische industrieën Aan alle deelnemers aan de najaarsvergadering De Nederlandse Vereniging voor Gastroenterologie kent een jarenlange samenwerking met de farmaceutische industrie. De vereniging stelt de farmaceutische industrie in de ge- legenheid aanwezig te zijn bij de wetenschappelijke vergaderingen met een stand. Mede hierdoor kan de vereniging haar wetenschappelijke bijeenkomsten organiseren. In het “besluit van 31 oktober 1994, Stb. 787, houdende regels voor reclame voor genees- middelen (Reclamebesluit Geneesmiddelen)” is onder andere geregeld wat wel en wat niet is toegestaan ten aanzien van gunstbetoning voor artsen door de farmaceutische industrie. De wet zegt dat - onder strikte voorwaarden - de farmaceutische industrie alleen reclame mag maken voor receptgeneesmiddelen voor personen die bevoegd zijn om dergelijke ge- neesmiddelen voor te schrijven. Alle andere personen (inclusief bijvoorbeeld verpleegkun- digen, endoscopie assistenten en biochemici) worden beschouwd als “publiek”. De farma- ceutische industrie mag geen reclame maken voor receptgeneesmiddelen voor publiek. De Nederlandse Vereniging voor Gastroenterologie is een wetenschappelijke vereniging voor personen die beroepsmatig betrokken zijn bij zorg, onderwijs en onderzoek ten behoeve van patiënten met maag-, darm- en leveraandoeningen. Dat betekent dat ook personen die geen arts zijn, lid van de NVGE kunnen zijn. De aanwezigheid van artsen, niet-artsen en farmaceutische industrieën tijdens de najaars- vergadering kan de NVGE ongewild in aanraking brengen met de inspectie voor de gezondheidszorg, sectie reclametoezicht, en daarmee in diskrediet worden gebracht. Dat willen wij te allen tijde voorkomen. Wij delen u dan ook het volgende mede: Reclame-uitingen en merkproductinformatie van farmaceutische industrieën in het voorlig- gende programmaboekje zijn alleen gericht op personen die bevoegd zijn om de betref- fende geneesmiddelen voor te schrijven. Al het aanwezige reclamemateriaal, reclame-uitingen en merkproductinformatie van far- maceutische industrieën die aanwezig zijn op het najaarscongres, zijn alleen bedoeld en alleen gericht op personen die bevoegd zijn om de betreffende geneesmiddelen voor te schrijven. Wij maken u erop attent dat het voor niet-artsen dan ook niet is toegestaan de stands van de aanwezige farmaceutische industrieën te bezoeken. De NVGE en farmaceutische industrie (sponsoren) meent u allen, en met name de niet BIG geregistreerde personen, voldoende te hebben ingelicht en kunnen niet verantwoorde- lijk worden gehouden indien u geen acht slaat op deze mededeling. Het bestuur van de NVGE 5 Cursorisch onderwijs in maag-darm-leverziekten, 6 oktober 2010 Auditorium Cursuscommissie: Prof. dr. P.D. Siersema (voorzitter) (MDL-arts, UMCU) Dr. B.B. van Elzen (aios MDL, AMC) Dr. E. van der Harst (chirurg, Maasstad Ziekenhuis) Dr. D.J. de Jong (MDL-arts, UMCN) Prof. dr. J.H. Kleibeuker (MDL-arts, UMCG) Drs. A.D. Koch (aios MDL, Erasmus MC) Dr. R. Timmer (MDL-arts, Antonius Nieuwegein) Onderwerp: Oncologie (premaligne afwijkingen) Voorzitter: Dr. D.J. de Jong, MDL-arts, UMC St. Radboud, Nijmegen 14.45 – 15.00 Evaluatie toets 15.00 – 15.30 Intestinale metaplasie van de maag Dr. A.C. de Vries, aios MDL, Erasmus MC, Rotterdam 15.30 – 16.00 Screening op HCC Dr. R.J. de Knegt, maag-darm-leverarts, Erasmus MC, Rotterdam. 16.00 – 16.30 Nieuwe endoscopische technieken voor detectie van colorectale poliepen Dr. E. Dekker, maag-darm-leverarts,
Load more

Recommended publications
  • Adherence to Surveillance Guidelines Following Colonic Polypectomy Is Abysmal
    170 Original Article Adherence to surveillance guidelines following colonic polypectomy is abysmal Frederick H. Koh1, Dedrick K. H. Chan1,2, Jingyu Ng3, Ker-Kan Tan1,2 1Division of Colorectal Surgery, University Surgical Cluster, National University Hospital, National University Health Systems, Singapore, Singapore; 2Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 3Division of Colorectal Surgery, Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore Contributions: (I) Conception and design: FH Koh, KK Tan; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: FH Koh, DK Chan, J Ng; (V) Data analysis and interpretation: FH Koh, DK Chan, J Ng; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Ker-Kan Tan. Division of Colorectal Surgery, University Surgical Cluster, National University Health System, 1E Kent Ridge Road, Singapore 119228, Singapore. Email: [email protected]. Background: Surveillance guidelines following excision of colonic tubular adenomas are well established. However, adherence to the guidelines are rarely audited. The aim of our study was to evaluate the rate of compliance to the recommended guidelines following polyp removal. Methods: A review of a prospectively collected colonoscopy database in a single tertiary institution was conducted for all patients who underwent polypectomy in 2008. We excluded patients who were diagnosed with or had prior history of colorectal malignancy. The frequency of subsequent colonoscopic were evaluated against the recommended guidelines based on the clinico-histological characteristics of the removed polyps. Results: There were 419 colonoscopies with polypectomies performed in 2008.
    [Show full text]
  • Issues in the Diagnosis and Management of Functional
    By BSc (Hons), Grad Dip Sc. Comm., Grad Dip Psych A thesis submitted for the degree of School of Medicine Faculty of Health Sciences June 2017 1 TABLE OF CONTENTS TABLE OF CONTENTS .............................................................................................................................2 LIST OF FIGURES AND TABLES ...................................................................................................................6 ABSTRACT ...........................................................................................................................................8 DECLARATION..................................................................................................................................... 10 ACKNOWLEDGEMENTS ........................................................................................................................... 11 CONFERENCE PRESENTATIONS ................................................................................................................. 12 ADDITIONAL PUBLICATIONS ARISING FROM THE PHD RESEARCH .......................................................................... 13 CHAPTER 1 : OVERVIEW ..................................................................................................... 14 References .................................................................................................................................. 17 CHAPTER 2 : INTRODUCTION .............................................................................................. 18
    [Show full text]
  • Laparoscopic Colorectal Surgery for Colorectal Polyps: Experience of Ten Years
    ACTA MEDICA LITUANICA. 2017. Vol. 24. No. 1. P. 18–24 © Lietuvos mokslų akademija, 2017 Laparoscopic colorectal surgery for colorectal polyps: experience of ten years Audrius Dulskas1, Background. Laparoscopy or its combination with endoscopy is the next step for “difficult” polyps. The purpose of the paper was to Žygimantas Kuliešius1, review the outcomes of the laparoscopic approach to the management of “difficult” colorectal polyps. Narimantas E. Samalavičius1, 2 Materials and methods. From 2006 to 2016, 58 patients who under- went laparoscopic treatment for “difficult” polyps that could not be treat- 1 Department of Abdominal and ed by endoscopy at the National Cancer Institute, Lithuania, were includ- General Surgery and Oncology, ed. The demographic data, the type of surgery, length of post-operative National Cancer Institute, stay, complications, and final pathology were reviewed prospectively. Vilnius, Lithuania Results. The mean patient was 65.9 ± 8.9 years of age. Laparoscop- ic mobilization of the colonic segment and colotomy with removal of 2 Clinic of Internal Diseases, Family Medicine and the polyp was performed in 15 (25.9%) patients, laparoscopic segmental Oncology, Faculty of Medicine, bowel resection in 41 (70.7%) cases: anterior rectal resection with par- Vilnius University tial total mesorectal excision in 18 (31.0%), sigmoid resection in nine Vilnius, Lithuania (15.5%), left hemicolectomy in seven (12.1%), right hemicolectomies in two (3.4%), ileocecal resection in two (3.4%), resection of transverse colon in two (3.4%), and sigmoid resection with transanal retrieval of specimen in one (1.7%). Two patients (3.4%) underwent laparoscopic- assisted endoscopic polypectomy. The mean post-operative hospital stay was 5.7 ± 2.4 days.
    [Show full text]
  • ASGE Program and Abstracts
    Volume 85, No. 5S : DDW Abstract Issue : May 2017 ASGE Program and Abstracts www.giejournal.org ASGE members: www.asge.org ELSEVIER ISSN-0016-5107 YYMGE_v85_i5_sS_COVER.inddMGE_v85_i5_sS_COVER.indd 1 119-04-20179-04-2017 222:46:532:46:53 ASGE Program SATURDAY, MAY 6 ASGE PRESIDENTIAL PLENARY SESSION 8:34 AM 8:00 AM-10:30 AM Endoscopic or Surgical Step-Up Approach for Necrotizing Pancreatitis, A Multi-Center Randomized MCP: ROOM S100AB Controlled Trial Moderators: Kenneth R. McQuaid, MD, FASGE, John J. Sandra van Brunschot* Vargo II, MD, MPH, FASGE, Karen L. Woods, MD, FASGE 8:37 AM 8:00 AM JACK A. VENNES, MD AND STEPHEN E. SILVIS, MD PRESIDENTIAL WELCOME AND OVERVIEW ENDOWED LECTURE 8:03 AM Introduction: What Jack and Steve Meant to the Two Over-the-Scope-Clips Versus Standard Endoscopic of Us and to Endoscopy Therapy in Patients With Recurrent Peptic Ulcer John Baillie, MBChB, FASGE, Martin L. Freeman, MD, Bleeding – A Prospective Randomized, Multicenter FASGE Trial (STING) Endoscopy in the Management of Pancreatic Arthur Schmidt*, Stefan Goelder, Helmut Messmann, Necrosis: Standard of Care? Martin Goetz, Thomas Kratt, Alexander Meining, Michael Martin L. Freeman, MD, FASGE Birk, Stefan von Delius, Joerg Albert, Markus Escher, James Y. Lau, Arthur Hoffman, Reiner Wiest, Karel Caca 8:54 AM 8:06 AM Bilateral Versus Unilateral Deployment of a Metal Stent for a Non-Resectable Malignant High-Grade Endoscopic Treatment of Recurrent Peptic Ulcer Hilar Biliary Stricture: A Multicenter Prospective Bleeding Pitfalls, Promise, and Progress Randomized
    [Show full text]
  • Expert Opinions and Scientific Evidence for Colonoscopy Key
    Gut Online First, published on October 8, 2016 as 10.1136/gutjnl-2016-312043 Recent advances in clinical practice Expert opinions and scientific evidence for colonoscopy key performance indicators Gut: first published as 10.1136/gutjnl-2016-312043 on 8 October 2016. Downloaded from Colin J Rees,1 Roisin Bevan,2 Katharina Zimmermann-Fraedrich,3 Matthew D Rutter,2 Douglas Rex,4 Evelien Dekker,5 Thierry Ponchon,6 Michael Bretthauer,7 Jaroslaw Regula,8 Brian Saunders,9 Cesare Hassan,10 Michael J Bourke,11 Thomas Rösch3 ▸ Additional material is ABSTRACT While colonoscopy can detect CRC and prevent it published online only. To view Colonoscopy is a widely performed procedure with by removal of adenomas,12 it can also lead to please visit the journal online procedural volumes increasing annually throughout the serious complications and quality measures should (http://dx.doi.org/10.1136/ 13–16 gutjnl-2016-312043). world. Many procedures are now performed as part of ensure that these are minimised. Additionally, fi colorectal cancer screening programmes. Colonoscopy poor quality colonoscopy is associated with For numbered af liations see 17 18 end of article. should be of high quality and measures of this quality increased rates of interval cancers. A major should be evidence based. New UK key performance challenge is to deliver high quality colonoscopy in Correspondence to indicators and quality assurance standards have been the setting of ever-increasing demand and activity. Professor Colin J Rees, developed by a working group with consensus England has seen a 20% increase in colonoscopy Department of agreement on each standard reached.
    [Show full text]
  • A Minor but Deadly Surgery of Colonic Polypectomy in an Elderly And
    Yuan et al. World Journal of Surgical Oncology (2016) 14:252 DOI 10.1186/s12957-016-1010-6 CASE REPORT Open Access A minor but deadly surgery of colonic polypectomy in an elderly and fragile patient: a case report and the review of literature Xiaoming Yuan1†, Guangrong Zhou1†, Yan He2 and Aiwen Feng1* Abstract Background: Epithelial dysplasia and adenomatous polyps of colorectum are precancerous lesions. Surgical removal is still one of the important treatment approaches for colorectal polyps. Case presentation: A male patient over 78 years was admitted due to bloody stool and abdominal pain. Colonoscopic biopsy showed a high-grade epithelial dysplasia in an adenomatous polyp of sigmoid colon. Anemia, COPD, ischemic heart disease (IHD), arrhythmias, and hypoproteinemia were comorbidities. The preoperative preparation was carefully made consisting of oral nutritional supplements (ONS), blood transfusion, cardiorespiratory management, and hemostatic therapy. However, his illness did not improve but deteriorate mainly due to polyp rebleeding during preparative period. The open polypectomy was performed within 60 min under epidural anesthesia. Postoperative treatments included oxygen inhalation, bronchodilation, parenteral and enteral nutrition, human serum albumin, antibiotics, and blood transfusion. Unluckily, these did not significantly facilitate to surgical recovery on account of severe comorbidities and complications. The most serious complications were colonic leakage and secondary abdominal severe infection. The patient finally gave up treatment due to multiple organ dysfunction syndromes. Conclusions: The polypectomy for colonic polyp is a seemingly minor but potentially deadly surgery for patients with severe comorbidities, and prophylactic ostomy should be considered for the safety. Keywords: Colonic polyp, Hypoproteinemia, Anemia, COPD, Arrhythmias, Polypectomy, Intestinal leakage, Abdominal infection Background prophylactic ostomy is not explicitly elaborated in many Adenomatous polyp and epithelial dysplasia are regarded literatures [1–5].
    [Show full text]
  • British Society of Gastroe
    Guidelines Endoscopy in patients on antiplatelet or Gut: first published as 10.1136/gutjnl-2015-311110 on 12 February 2016. Downloaded from anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines Andrew M Veitch,1 Geoffroy Vanbiervliet,2 Anthony H Gershlick,3 Christian Boustiere,4 Trevor P Baglin,5 Lesley-Ann Smith,6 Franco Radaelli,7 Evelyn Knight,8 Ian M Gralnek,9,10 Cesare Hassan,11 Jean-Marc Dumonceau12 For numbered affiliations see ABSTRACT guidelines on the management of acute non- end of article. The risk of endoscopy in patients on antithrombotics variceal upper gastrointestinal bleeding.1 Correspondence to depends on the risks of procedural haemorrhage versus Recommendations for the management of Dr Andrew Veitch, Department thrombosis due to discontinuation of therapy. patients on antiplatelet therapy or anticoagulants of Gastroenterology, New P2Y12 receptor antagonists (clopidogrel, undergoing elective endoscopic procedures are out- Cross Hospital, Wolverhampton prasugrel, ticagrelor) For low-risk endoscopic lined in the algorithms in figures 1 and 2. Risk WV10 0QP, UK; procedures we recommend continuing P2Y12 receptor stratification for endoscopic procedures and anti- [email protected] antagonists as single or dual antiplatelet therapy (low platelet agents (APAs) are detailed in tables 1 and This article is published quality evidence, strong recommendation); For high-risk 2. There is no high-risk category of thrombosis for simultaneously in the journal endoscopic procedures in patients at low thrombotic risk, DOACs as they are not indicated for prosthetic Endoscopy. Copyright 2016 © we recommend discontinuing P2Y12 receptor metal heart valves. Warfarin risk stratification is Georg Thieme Verlag KG antagonists five days before the procedure (moderate detailed in table 3.
    [Show full text]
  • Endoscopic Removal of Colorectal Lesions—Recommendations by The
    US MULTI-SOCIETY TASK FORCE Endoscopic Removal of Colorectal LesionsdRecommendations by the US Multi-Society Task Force on Colorectal Cancer Tonya Kaltenbach,1 Joseph C. Anderson,2,3,4 Carol A. Burke,5 Jason A. Dominitz,6,7 Samir Gupta,8,9 David Lieberman,10 Douglas J. Robertson,2,3 Aasma Shaukat,11,12 Sapna Syngal,13 Douglas K. Rex14 This article is being published jointly in Gastrointestinal Endoscopy, Gastroenterology, and The American Journal of Gastroenterology. Colonoscopy with polypectomy reduces the incidence injection to lift the lesion before snare resection, have of and mortality from colorectal cancer (CRC).1,2 It is the evolved to improve complete and safer resection. The cornerstone of effective prevention.3 The National Polyp primary aim of polypectomy is the complete and safe Study showed that removal of adenomas during removal of the colorectal lesion and the ultimate preven- colonoscopy is associated with a reduction in CRC tion of CRC. This consensus statement provides recom- mortality by up to 50% relative to population controls.1,2 mendations to optimize complete and safe endoscopic The lifetime risk to develop CRC in the United States is removal techniques for colorectal lesions (Table 1), approximately 4.3%, with 90% of cases occurring after the based on available literature and experience. The age of 50 years.4 The recent reductions in CRC incidence recommendations from the US Multi-Society Task force and mortality have been largely attributed to the (USMSTF) on the management of malignant polyps, polyp- widespread uptake of CRC screening with polypectomy.5 osis syndromes,8 and surveillance after colonoscopy and The techniques and outcomes of polyp removal using polypectomy9 are available in other documents.
    [Show full text]
  • Safety and Efficacy of Hot Avulsion As an Adjunct to Endoscopic Mucosal Resection (With Videos)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by IUPUIScholarWorks ACCEPTED MANUSCRIPT Safety and efficacy of hot avulsion as an adjunct to endoscopic mucosal resection (with videos) Vinod Kumar MD1 Heather Broadley 2 Douglas K. Rex MD2 1Indiana University Health Methodist Hospital 2Division of Gastroenterology/Hepatology, Department of Medicine, Indiana University School of Medicine Author contributions: Kumar: data retrieval, drafting of the manuscript, data and statistical analysis Broadley: data retrieval, critical review and approvalMANUSCRIPT of the manuscript Rex: study design, critical revision of the manuscript Conflicts of Interest: Dr. Rex is a consultant to Olympus America Corporation and Boston Scientific. None of the other authors identified a conflict of interest. Please send correspondence to: Douglas K. Rex University Hospital 550 North University Blvd Suite 4100 Indianapolis, IN ACCEPTED 46202 [email protected] This work was funded by a gift from Scott Schurz and his children to the Indiana Uni- versity Foundation, in the name of Douglas K Rex. ___________________________________________________________________ This is the author's manuscript of the article published in final edited form as: Kumar, V., Broadley, H., & Rex, D. K. (2018). Safety and efficacy of hot avulsion as an adjunct to endoscopic mucosal resection (with videos). Gastrointestinal Endoscopy. https://doi.org/10.1016/j.gie.2018.11.032 ACCEPTED MANUSCRIPT Abstract: Background: Excision of all visible neoplastic tissue is the goal of endoscopic mucosal resec- tion (EMR) of colorectal laterally spreading tumors (LSTs). Flat and fibrotic tissue can resist snaring. Ablation of visible polyps is associated with high recurrence rates. Avulsion is a technique to continue resection when snaring fails.
    [Show full text]
  • Download of These Slides, Please Direct Your Browser to the Following Web Address
    Clinical Roundtable Monograph Gastroenterology & Hepatology August 2018 Incomplete Resection Rates in Polyps Smaller Than 2 Centimeters Proceedings From a Live Clinical Roundtable Held During Digestive Disease Week • June 2-5, 2018 • Washington, DC Moderator David A. Johnson, MD Professor of Medicine Chief of Gastroenterology Eastern VA Medical School Norfolk, Virginia Discussants Michael B. Wallace, MD, MPH Professor of Medicine Mayo Clinic Jacksonville, Florida Vivek Kaul, MD, FACG, FASGE, AGAF Segal-Watson Professor of Medicine Chief, Division of Gastroenterology & Hepatology Center for Advanced Therapeutic Endoscopy University of Rochester Medical Center Rochester, New York Tonya Kaltenbach, MD, MS Associate Professor of Clinical Medicine University of California, San Francisco San Francisco, California Abstract: Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in the United States. Colonoscopy is the most effective strategy for preventing CRC. Although the benchmark of colonoscopy performance, the adenoma detection rate, clearly correlates with prevention of interval cancers and CRC-related death, it is clear that polyp (adenoma) detection is not enough. Adequate and complete resection of the adenoma is imperative to ensure effective CRC prevention. Polyp size is the primary risk factor for malignancy; in general, the bigger the polyp, the greater the risk for malignancy. This monograph, however, focuses on strategies to improve the incomplete resection rate for polyps smaller than 2 cm, as these represent the vast majority of polyps encountered in clinical practice. Selection of the polypectomy technique depends on the size and type of polyp. In general, cold forceps biopsy is used for polyps smaller than 4 mm, cold snare polypectomy is used for polyps 4 to 10 mm, and hot snare polypectomy and endoscopic mucosal resection (EMR) are highly effective for larger polyps.
    [Show full text]
  • Entrustable Professional Activities for General Surgery
    Entrustable Professional Activities for General Surgery 2020 VERSION 1.0 General Surgery: Foundations EPA #1 Assessing and providing initial management plans for patients presenting with a simple General Surgery problem Key Features: - This EPA includes conducting an appropriate history and physical examination, ordering and interpreting investigations, generating provisional and differential diagnoses, and developing and communicating a management plan for patients with simple surgical problems. Assessment Plan: Direct and indirect observation by surgeon, surgical fellow, or Core or TTP resident Use Form 1. Form collects information on: - Setting: inpatient; outpatient; emergency - Observation: direct; indirect Collect 5 observations of achievement - At least 1 direct observation - At least 2 different observers - At least 3 observations by faculty Relevant Milestones: 1 ME 1.5 Recognize urgent problems that may need the involvement of more experienced colleagues and seek their assistance 2 ME 2.2 Elicit an accurate, concise, and relevant history 3 ME 2.2 Perform a physical exam that informs the diagnosis 4 ME 2.2 Develop a differential diagnosis relevant to the patient’s presentation 5 ME 2.2 Select and/or interpret appropriate investigations, including imaging 6 ME 2.4 Develop and implement a plan for initial management © 2019 The Royal College of Physicians and Surgeons of Canada. All rights reserved. This document may be reproduced for educational purposes only provided that the following phrase is included in all related materials: Copyright © 2019 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission. Please forward a copy of the final product to the Office of Specialty Education, attn: Associate Director, Specialties.
    [Show full text]
  • Intraoperative Transanal Fiberoptic Colonoscopy: Report of Six Cases Thomas A
    Henry Ford Hospital Medical Journal Volume 25 | Number 1 Article 5 3-1977 Intraoperative transanal fiberoptic colonoscopy: Report of six cases Thomas A. Fox Jr. Peter A. Haas Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Fox, Thomas A. Jr. and Haas, Peter A. (1977) "Intraoperative transanal fiberoptic colonoscopy: Report of six cases," Henry Ford Hospital Medical Journal : Vol. 25 : No. 1 , 33-36. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol25/iss1/5 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. Henry Ford Hosp Med Journal Vol 25, No 1, 1977 Intraoperative transanal fiberoptic colonoscopy Report of six cases Thomas A. Fox, Jr., MD and Peter A. Haas, MD* Intraoperative transanal fiberoptic colo­ THE use of the flexible fiberoptic colono- noscopy is presented as an alternative to scope in thediagnosisof colonic disease and transcolonic procedures to remove colonic the removal or biopsy of most colonic le­ polyps, or to excise or biopsy other intra­ sions located above the rectosigmoid have luminal les ions. This method should be con­ become fairly well standardized. The advan­ sidered when the standard transanal tages of this techn ique are its safety'" and the colonoscopy has failed. The results with this lack of the operative complications which procedure have been excellent. The method may occur with a laparotomy and trans­ also can be applied to patients who have colonic polypectomy, excision or biopsy.
    [Show full text]